A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes
about
Dangerous liaisons: how the immune system deals with factor VIIIFVIII inhibitors: pathogenesis and avoidanceThe mannose receptorBridging innate and adaptive antitumor immunity targeting glycans.Expression of Aspergillus nidulans phy gene in Nicotiana benthamiana produces active phytase with broad specificities.A major determinant of the immunogenicity of factor VIII in a murine model is independent of its procoagulant function.Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014.The C1 and C2 domains of blood coagulation factor VIII mediate its endocytosis by dendritic cells.Increasing recombinant protein production in Escherichia coli through metabolic and genetic engineering.Cross-presentation: how to get there - or how to get the ER.Glycosylation: impact, control and improvement during therapeutic protein production.On the versatility of von Willebrand factorInhibitors in haemophilia A: a perspective on clotting factor products as a potential contributing factor.Therapeutic factor VIII does not trigger TLR1.2 and TLR2.6 signalling in vitro.Factor VIII inhibitors: Advances in basic and translational science.Isotope labeling in insect cells.HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII.Pichia pastoris secretes recombinant proteins less efficiently than Chinese hamster ovary cells but allows higher space-time yields for less complex proteinsModification of an exposed loop in the C1 domain reduces immune responses to factor VIII in hemophilia A mice.Limited promiscuity of HLA-DRB1 presented peptides derived of blood coagulation factor VIII.Predictive immunogenicity of Refacto AF.Complement C3 is a novel modulator of the anti-FVIII immune response.Immunoprotective effect of von Willebrand factor towards therapeutic factor VIII in experimental haemophilia A.Double adjuvanting strategy for peptide-based vaccines: trimethyl chitosan nanoparticles for lipopeptide delivery.
P2860
Q27000818-6A100C10-0656-4116-A396-A2A7D773C82EQ27027224-E21AD39A-090D-4B81-9012-4D936E780292Q28274841-CA99D2A5-A8DF-4DC6-836E-4B0B0A651548Q33960021-BF330303-3A05-42AD-94D6-52CDAC7BB550Q34358440-7F35B7AE-9372-49B9-9EBA-8874CD51CD20Q36250957-DD1C7CC4-82B7-4977-A4BC-30D4179A1FC0Q37185097-8BDD4989-C9DC-4163-896E-C5E1A4D6A03CQ37618821-89BF17D1-DA88-4478-9633-BA2061629412Q37928986-29743FAC-8CF3-4481-BDF8-C006239CA9FDQ38008346-F08EC883-DB34-40F4-94D7-98069C38501BQ38126913-A5C03887-4DC6-44E1-B8A9-07E68A789074Q38128303-9AF02AEC-1001-4BF4-B7A0-BE4DDFF56087Q38722283-E5519E4E-B8E7-41E8-A600-FE16F5A4209AQ39223774-EB04A5DC-CCAF-477F-80E6-EFC2E3F68DE0Q39266287-49B0B72C-D899-4994-B147-5C6464B58E46Q39428821-CD1411B8-2C5D-4ADF-85A0-785A000AADDDQ41821071-3B7DB0A7-90A4-4D78-BA08-5E61DC8E9D3FQ41986845-E64AAA9E-07FE-44F7-A232-158836B74A59Q42096639-F2910501-6900-4781-B57D-0C4F71AB704FQ42133506-B2B51EDA-1946-4751-B602-3578DEAFE9EFQ45861147-8747FDEB-9EAE-4474-A1ED-AB9E434DD4DAQ45874563-F2A49448-4026-4178-8106-2E5590020853Q45874622-EC01557C-E357-4196-AD19-8415843C58CAQ48938733-64634B46-EBDE-4508-8420-772F19A82AC3
P2860
A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A role for exposed mannosylati ...... proteins to CD4+ T lymphocytes
@ast
A role for exposed mannosylati ...... proteins to CD4+ T lymphocytes
@en
type
label
A role for exposed mannosylati ...... proteins to CD4+ T lymphocytes
@ast
A role for exposed mannosylati ...... proteins to CD4+ T lymphocytes
@en
prefLabel
A role for exposed mannosylati ...... proteins to CD4+ T lymphocytes
@ast
A role for exposed mannosylati ...... proteins to CD4+ T lymphocytes
@en
P2093
P2860
P50
P356
P1476
A role for exposed mannosylati ...... proteins to CD4+ T lymphocytes
@en
P2093
Ana-Maria Navarrete
Jean-Marie Saint-Remy
Marc Jacquemin
Michel D Kazatchkine
Michelina Nascimbeni
Sandrine Delignat
Srinivas V Kaveri
Suryasarathi Dasgupta
Sébastien André
Teunis B H Geijtenbeek
P2860
P304
P356
10.1073/PNAS.0702120104
P407
P50
P577
2007-05-14T00:00:00Z